Krka, d. d.

Warsaw Stock Exchange KRK.WA

Krka, d. d. Return on Equity (ROE) for the year ending December 31, 2023: 14.52%

Krka, d. d. Return on Equity (ROE) is 14.52% for the year ending December 31, 2023, a -15.32% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Krka, d. d. Return on Equity (ROE) for the year ending December 31, 2022 was 17.15%, a 5.66% change year over year.
Krka, d. d. Return on Equity (ROE) for the year ending December 31, 2021 was 16.23%, a -2.77% change year over year.
Krka, d. d. Return on Equity (ROE) for the year ending December 31, 2020 was 16.69%, a 13.14% change year over year.
Krka, d. d. Return on Equity (ROE) for the year ending December 31, 2019 was 14.75%, a 29.93% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Warsaw Stock Exchange: KRK.WA

Krka, d. d.

CEO	Dr. Joe Colaric
IPO Date	April 11, 2012
Location	Slovenia
Headquarters	Šmarješka cesta 6
Employees	12,675
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Dairy & Milk Drugstores & Retail Pharmacies Personal Care Pet Food Tobacco

Description

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.

Key trends

Past 5 years